Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Frontera London

- PMLiVE

ViiV chalks up another win for two-drug HIV regimen

Once a month injection matches triple oral therapy

- PMLiVE

Daily Brief: another departure at Gilead, veteran researcher to head up Karuna

Exodus continues from Gilead

- PMLiVE

Anti-ageing gets another boost with Napa Therapeutics launch

Juvenescence teams up with Insilico Medicines and Buck Institute

- PMLiVE

Industry appointments

Vivaldi heads up Sigilon, Pfizer Oncology loses its CMO and Zelluna appoints new CSO

- PMLiVE

Realm toppled by second mid-stage trial flop

The hypochlorous acid gel failed to show EASI score improvement compared to placebo

- PMLiVE

Your excellent marketing team: let the world know about it

Deadline of 30 August for PMEA awards fast approaching

Keytruda’s secret sauce

Merck’s position in oncology is about much more than a good product

- PMLiVE

Shock as NICE turns down Biogen’s SMA therapy

UK’s cost effectiveness watchdog says the drug’s long-term benefits are unclear

- PMLiVE

Paramount Recruitment reveals Communiqué Casino winners

Bayer’s Chris Henry and Edelman’s Nilüfer Münür win the prizes

- PMLiVE

Daily Brief: DeepMind and NHS success in AI, Bayer invests in COPD, Alecensa OK in Scotland

The latest from pharma, biotech and healthcare

- PMLiVE

After Cohen payment scandal, Novartis unveils new ethics chief

New 'risk and compliance' leader has increased powers

- PMLiVE

AI company Sensyne raises £60m in IPO

University of Oxford-developed tech powers health-focused company

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links